Skip to main content
Equibles

MPM BIOIMPACT LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1687078 BOSTON, MA
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$30,645,000
+$23,822,272 QoQ
Shares Held
4,500,000
+52.4% QoQ
Ownership
1.38%
of shares outstanding
% of Portfolio
1.87%
of 13F equity value
Holder Rank
#15
of 208 holders
Holding Since
Jun 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MPM BIOIMPACT LLC holds $1,463,416,616 across 34 Biotechnology names. TSHA ranks #19 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGEM
Cullinan Therapeutics, Inc.
 9,731,341 $177,207,719
2 AKTS
Aktis Oncology, Inc.
 4,835,872 $155,860,154
3 RVMD
Revolution Medicines, Inc.
 492,483 $92,232,216
4 CORT
Corcept Therapeutics Inc
 771,028 $67,040,884
5 EWTX
Edgewise Therapeutics, Inc.
 1,620,780 $65,852,291
6 TVTX
Travere Therapeutics, Inc.
 1,122,731 $63,782,348
7 DBVT
DBV Technologies S.A.
 3,666,284 $60,127,057
8 TRVI
Trevi Therapeutics, Inc.
 3,073,577 $57,322,211

All Filings in TSHA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,645,000 4,500,000
2025-06-30 $6,822,728 2,953,562